What's New at The Body
HIV/AIDS News You Can Use
December 20, 2001
ICAAC Inside and Out: Conference CoverageRead The Body's stellar coverage of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. Ten of the U.S.' most outstanding HIV specialists were on hand and brought back a variety of interesting reports.
Despite the increasing prevalence of HIV drug resistance in the U.S., a study has found some comforting news: HIV practitioners who see the most patients are less likely to find HIV drug resistance in those patients. Dr. Mark Holodniy reports on the details.
A hot topic at ICAAC was structured treatment interruptions, both in newly HIV-infected people and those who have well-established infections. Dr. Cal Cohen reviews one presentation.
When a drug regimen appears to begin losing its effectiveness, when is the right time to switch -- and would a patient be better off going on structured treatment interruption instead? Dr. Cal Cohen reports on this controversial treatment issue.
"Lipodystrophy is due to several causes that may occur simultaneously and affect different people in different ways. The challenge for the future is to identify these causes and attempt to intervene in a cause-based manner." Dr. Alvan Fisher writes about the metabolic complications of HIV treatment.
Dr. Paul Sax takes a look at a new anti-HIV drug, emtricitabine, that is over five times more potent than 3TC.
Atazanavir and saquinavir combination therapy is effective and spares lipids, reports Dr. Brian Boyle.
Good Girls Get HIV TooToo many women diagnosed with HIV are given the message that "good" girls don't get HIV. Social worker Tobi Newman writes about some of the emotional issues facing women with HIV, in HIV Treatment ALERTS!
Anti-HIV Meds and Birth Defects?The use of anti-HIV drugs by HIV-positive pregnant women has greatly increased over the past decade. There are concerns, though, that while these drugs work wonders to reduce a mother's risk of exposing her baby to HIV, they may also increase the risk of birth defects when combined with other medications. The Canadian AIDS Treatment Information Exchange brings us the latest research results.
Safely Having -- and Making -- ChildrenDr. Nancy Eriksen describes new reproductive options for HIV-infected patients, in HIV Treatment ALERTS!
448,060 Dead, 774,467 Diagnosed: The AIDS TollTake a look at the latest U.S. statistics for HIV/AIDS by race, risk category, region, and more.
Astroglide, Unwanted Fat, and Magic (Oh My)The positive effects of lubricants, the high occurrence of lipodystrophy in women, an update on Magic Johnson's condition and much more, in Positively Aware's Newsbriefs.
The Breast Is Yet to Come?"One would hope that one never has to face breasts against one’s will! However, with the evolving field and treatment of HIV and its related complications, breast tissue can emerge as a challenge for both patients and their physicians." Dr. Daniel Berger writes about breast fat accumulation, in Positively Aware.
The Tradition Continues: Another 'F' for BushLambda issues its 2001 World AIDS Day Report Card and flunks the Bush Administration for its just-say-no approach to sex education for young people at risk of infection.
New Anti-Cancer Therapy Saves WomanCastleman's disease, a rare HIV complication caused by the same virus that causes Kaposi's sarcoma, was effectively treated with the new anti-cancer drug Rituxan.
IDSA Update: Sexually Transmitted Infections and HIV